ArticleFrontiers in endocrinology2023

Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension.

Mônica Gadelha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.